Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

NCT07564570 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitätsklinikum Hamburg-Eppendorf